Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer - Attia, S; Eickhoff, J; Wilding, G; McNeel, D; Blank, J; Ahuja, H; Jumonville, A; Eastman, M; Shevrin, D; Glode, M (Clin Cancer Res, 2008)